Press Release: Sensorion : Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emery's Life Sciences Symposium

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 - ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, is pleased to announce its participation, in-person, at the Jefferies London Healthcare Conference and at McDermott Will & Emery's Life Sciences Symposium. CEO Nawal Ouzren will attend Jefferies London Healthcare